logo-loader

Clinigen boss happy with contribution from all divisions in latest half year

Published: 10:26 16 Mar 2017 GMT

Shaun Chilton, chief executive at Clinigen Group PLC (LON:CLIN), told Proactive he was very happy with the firm's latest half year.
The specialty pharma group confirmed that underlying profits [adjusted EBITDA] rose 34% to £30mln in the half year to end December on revenues of £131mln (£156mln)
"I think it's a strong performance and particularly because every single business division contributed," he told Andrew Scott.

FTSE rises ahead of Easter weekend, JD Sport gains on upbeat outlook -...

The FTSE 100 gained on the final morning of this shortened Easter trading week. Festive cheer was limited though, as Thames Water confirmed shareholders would not provide it with a £500 million rescue package, prompting speculation over the London supplier’s future. On a more positive...

40 minutes ago